An intriguing focus on prolactin and the expression of a diabetic phenotype. New developments on the horizon

European Journal of Clinical InvestigationEarly View e14230 EDITORIAL An intriguing focus on prolactin and the expression of a diabetic phenotype. New developments on the horizon Marcel Th B Twickler, Corresponding Author Marcel Th B Twickler [email protected] orcid.org/0000-0001-8738-207X Department of Endocrinology, Diabetology and Metabolic Diseases, AZ Monica Deurne, Deurne, Belgium Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium Correspondence Marcel Th B Twickler, Department of Endocrinology, Diabetology and Metabolic Diseas AZ Monica Deurne, Fl Pauwelslei 1, Deurne 2100, Belgium. Email: [email protected]Search for more papers by this author Marcel Th B Twickler, Corresponding Author Marcel Th B Twickler [email protected] orcid.org/0000-0001-8738-207X Department of Endocrinology, Diabetology and Metabolic Diseases, AZ Monica Deurne, Deurne, Belgium Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium Correspondence Marcel Th B Twickler, Department of Endocrinology, Diabetology and Metabolic Diseas AZ Monica Deurne, Fl Pauwelslei 1, Deurne 2100, Belgium. Email: [email protected]Search for more papers by this author First published: 22 April 2024 https://doi.org/10.1111/eci.14230Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol. 2002; 64: 47-67. 10.1146/annurev.physiol.64.081501.131049 CASPubMedWeb of Science®Google Scholar 2Riddle O, Bates RW, Dykshorn SW. The preparation, identification and assay of prolactin—a hormone of the anterior pituitary. Am J Physiol-Legacy Content. 1933; 105(1): 191-216. 10.1152/ajplegacy.1933.105.1.191 CASGoogle Scholar 3Scairati R, Auriemma RS, Del Vecchio G, Di Meglio S, Pivonello R, Colao A. Prolactin effects on the pathogenesis of diabetes mellitus. Eur J Clin Investig. 2024;e14190. doi:10.1111/eci.14190 10.1111/eci.14190 PubMedWeb of Science®Google Scholar 4Stewart C, Marshall CJ. Seasonality of prolactin in birds and mammals. J Exp Zool A Ecol Integr Physiol. 2022; 337(9–10): 919-938. 10.1002/jez.2634 PubMedWeb of Science®Google Scholar 5Goffin V, Bernichtein S, Touraine P, Kelly PA. Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev. 2005; 26(3): 400-422. 10.1210/er.2004-0016 CASPubMedWeb of Science®Google Scholar 6Reuwer AQ, Nieuwland R, Fernandez I, et al. Prolactin does not affect human platelet aggregation or secretion. Thromb Haemost. 2009; 101(6): 1119-1127. 10.1160/TH08-12-0801 CASPubMedWeb of Science®Google Scholar 7Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, et al. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J Endocrinol. 2011; 208(2): 107-117. 10.1677/JOE-10-0076 CASPubMedWeb of Science®Google Scholar 8Molitch ME. Prolactin and pregnancy. In: N Tritos, A Klibanski, eds. Prolactin Disorders. Contemporary Endocrinology. Humana, Cham; 2019. doi:10.1007/978-3-030-11836-5_9 10.1007/978-3-030-11836-5_9 Google Scholar 9Reuwer AQ, Reuwer PJHM, van der Post JA, Cramer MJ, Kastelein JJP, Twickler MTB. Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia. Med Hypotheses. 2010; 74(2): 348-352. 10.1016/j.mehy.2009.08.029 CASPubMedWeb of Science®Google Scholar 10Tang MW, Reedquist KA, Garcia S, et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford). 2016; 55(12): 2248-2259. 10.1093/rheumatology/kew316 CASPubMedWeb of Science®Google Scholar 11Devaraj S, Dasu MR, Jialal I. Diabetes is a proinflammatory state: a translational perspective. Expert Rev Endocrinol Metab. 2010; 5(1): 19-28. 10.1586/eem.09.44 CASPubMedGoogle Scholar 12Triebel J, Bertsch T, Clapp C. Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited. Front Endocrinol (Lausanne). 2022; 13:994898. 10.3389/fendo.2022.994898 PubMedWeb of Science®Google Scholar 13Reuwer AQ, Nowak-Sliwinska P, Mans LA, et al. Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology? J Cell Mol Med. 2012; 16(9): 2035-2048. 10.1111/j.1582-4934.2011.01499.x CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issuee14230 ReferencesRelatedInformation